Dr Timothy J. Miller | President and CEO
Abeona Therapeutics

Dr Timothy J. Miller, President and CEO, Abeona Therapeutics

Abeona Therapeutics (NASDAQ: ABEO) is clinical stage biopharmaceutical company focused on delivering gene therapy products for severe and life-threatening rare diseases. Our lead indications are for children with the rare genetic metabolic and dermatologic disorders, Sanfilippo syndrome, Batten disease and Epidermolysis bullosa. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases.


Day 1 Orphan 14th Nov @ 15:40

Resource management: Strategies enabling the efficient development of multiple promising gene therapy programs – even as a smaller company

  • Clinical trial updates
  • The importance of education and communication for accelerated program progression

back to speakers